The artificial sweetener that's been a staple in American households for decades is now facing fresh scrutiny, as emerging ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

U-500 insulin human regular (Humulin R U-500 ... inhospital hypoglycemia (e.g., oral carbohydrates; i.v. 50% dextrose solution) will be followed as in other hospitalized patients.

The global Insulin Delivery Devices Market was valued at USD 30.9 billion in 2022 and is expected to grow significantly, ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

Olive oil bioactives, including MUFAs, polyphenols, and triterpenoids, modulate gene expression linked to insulin sensitivity ...

Merilog is a rapid-acting human insulin analog designed to reduce spikes ... only for patients needing effective diabetes management solutions but also for the overall landscape of diabetic ...

The Republican-controlled State Senate has joined the DFL-controlled House to advance a proposed emergency insulin bill. In mid-February, the Minnesota Senate established a plan to give ...

Dr Anne Peters concludes her discussion of the ADA Standards of Care with a look at sections on kidney care, pregnancy care, and cardiovascular disease management in patients with diabetes.

Not everyone with type 2 diabetes has to take insulin. But if you do, you and your doctor will decide the best schedule and insulin dose for you. You may also need to figure out some dosages on ...